How smarter product choices can improve patient care, reduce waste and support more sustainable prescribing in primary care.

Dry eye disease is one of the most common ocular conditions managed across primary care, community pharmacy and optometry. With an ageing population, increasing digital screen use and a growing number of patients living with chronic conditions that affect tear production, demand for effective, long-term treatment continues to rise.

Today, selecting an artificial tear is about more than simply relieving symptoms. Ease of use, preservative exposure, product longevity and overall value all influence patient adherence, treatment success and the efficient use of NHS resources. This is where thoughtful product design can make a real difference.

Supporting patients at every stage of dry eye

No two patients experience dry eye disease in the same way, which is why ClinOptic™ HA is available in three strengths of sodium hyaluronate – 0.1%, 0.21% and 0.4%. This enables healthcare professionals to tailor treatment according to symptom severity, from mild and intermittent dry eye through to more persistent or severe disease.

Offering a consistent product range also provides continuity for patients, allowing treatment to be adjusted while maintaining the same preservative-free formulation and easy-to-use delivery system.

Preservative-free, designed around the patient

For patients requiring long-term treatment, preservative-free eye drops are widely recognised as the preferred choice, helping to minimise the risk of ocular surface irritation associated with repeated preservative exposure.

ClinOptic™ HA combines a preservative-free formulation with an innovative Aero Pump delivery system, allowing sterile eye drops to be dispensed throughout the life of the bottle without the need for preservatives.

The pump mechanism has also been designed with patients in mind. Requiring less force than many conventional squeeze bottles, it can be particularly beneficial for people living with arthritis, reduced grip strength or other dexterity challenges. By making administration easier, healthcare professionals can help patients use their treatment more confidently and consistently.

Better value for patients and the NHS

With increasing pressure on NHS budgets, prescribing decisions must balance clinical effectiveness with value for money.

At just £4.15 on the NHS Drug Tariff, ClinOptic™ HA is the lowest-priced preservative-free multi-dose pump eye drop currently available. Despite its competitive price, every bottle delivers approximately 350 measured drops together with an impressive six-month in-use shelf life after opening.

Many preservative-free multi-dose eye drops have an in-use shelf life of between 8 weeks and 3 months, meaning partially used bottles may need to be discarded before they are fully utilised.

The combination of a higher drop count and an extended six-month in-use period means patients may require fewer replacement bottles throughout the year, helping to reduce medicine waste while supporting ongoing treatment adherence.

For the NHS, this has the potential to improve prescribing efficiency and maximise the value obtained from every prescription. For patients, it provides a convenient long-term solution that can continue to be used for up to six months after opening when used in accordance with the instructions for use.

A best practice approach to dry eye management

Dry eye disease is often managed collaboratively between GPs, community pharmacists, practice nurses and optometrists. Choosing products that are clinically appropriate, easy to administer and designed to reduce waste supports a more patient-centred approach to care while helping healthcare systems make the best use of available resources.

ClinOptic™ HA reflects this approach by combining a preservative-free formulation, three clinically appropriate strengths, an easy-to-use Aero Pump delivery system, approximately 350 drops per bottle, a six-month in-use shelf life, and the lowest NHS Drug Tariff price for a preservative-free multi-dose pump eye drop.

As demand for dry eye management continues to grow, healthcare professionals have an opportunity to look beyond the formulation alone and consider how product design can improve real-world outcomes. Sometimes, delivering best practice isn't about doing more, it's about choosing better.

When every drop counts, every decision matters.

Choose an eye drop that supports your patients, your practice and the NHS. Discover why more healthcare professionals are making every drop count with ClinOptic™ HA.

Learn more about ClinOptic™ HA

For more information about ClinOptic™ HA, or to request a sample, please contact the Penlan Healthcare Medical Device Team at info@penlanhealth.com.

ClinOptic™ is a trademark of Pemberton Laboratories (UK) Limited.